Paid Clinical Trials in Denver

Dr. Ahmed Zayed

Written by Dr. Ahmed Zayed

Board-certified Physician | Graduate w/ Honors Faculty of Medicine | Alexandria, Egypt

Updated & Fact Checked 7/30/26

Denver’s research runs mostly through specialty centers rather than one large university hospital. As of July 2026, 524 studies are actively recruiting in the city, according to ClinicalTrials.gov, with blood cancer, respiratory medicine, and community oncology accounting for much of the activity.

Clinical Research in Denver

Denver’s medical research maintains high enrollment and quality standards in all their clinical trials. With access to a large population, healthcare experts and scientists often meet the enrollment goals and conduct thorough research.

Clinical trials in Denver are performed in accordance with FDA, ICH, and GCP guidelines. Scientists are committed to providing top-quality care and improving medicine through innovation.

Our platform is here to bridge that gap between research facilities and volunteers eager to participate. Keep reading to find out more.

Quick Facts: Paid Clinical Trials in Denver

  • Actively recruiting studies (July 2026): 524 (ClinicalTrials.gov)
  • Typical compensation: $50–$100 per completed outpatient visit; residential Phase 1 studies pay more (see highest paid clinical trials)
  • Cost to participate: $0 — study care and visits are covered by the sponsor
  • Worth knowing: the University of Colorado’s Anschutz campus is in Aurora, not Denver — search both cities to see everything nearby
  • Statewide options: paid clinical trials in Colorado

Where Denver trials actually run

We sampled recruiting Denver studies on ClinicalTrials.gov in July 2026. The sites running the most trials:

Research siteTrials sampled
Colorado Blood Cancer Institute57
National Jewish Health35
AdventHealth Porter29
Rocky Mountain Cancer Centers (Midtown and Rose)44
Sarah Cannon Research Institute at HealthONE22

National Jewish Health is the country’s leading respiratory hospital, which makes Denver a strong place to find asthma, COPD, and lung disease studies. Note that the University of Colorado’s large research campus sits in neighboring Aurora, so searching Aurora as well as Denver widens your options considerably.

Clinical Trials For Disease Areas in Denver 

Denver research centers are dedicated to conducting clinical trials in areas of internal medicine, respiratory health, neurology, rheumatology, rare diseases, pediatrics, and women’s health. 

Neurology is one of the biggest clinical research enterprises at the University of Colorado School of Medicine. Experts are currently running more than 290 active studies and clinical trials in various stages. 

They collaborate with experts from around the world, including top academic institutions and leaders in clinical research. This institution provides a wide range of clinical studies, such as drug studies, non-drug interventions, medical device research, biobanking, quality improvements, and more.

Both UCHealth and Children’s Hospital Colorado actively study rare diseases. They have specialized initiatives aimed at providing tailored care for individuals diagnosed with rare conditions, such as Children’s Hospital Colorado’s newly launched Precision Medicine program.

According to recent data from the U.S. clinical trials, there are over 4,000 ongoing trials within their facilities. A major portion of these trials are dedicated to studying rare diseases. Such as trials on molecular and gene therapies.

Your participation can make a difference. Sign up for a clinical trial in Denver today!

Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Gender:
ALL
Ages:
All
Trial Updated:
09/20/2024
Locations: Univ of Southern California / LA County USC Med Ctr, Los Angeles, California
Conditions: HIV Infections
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis... Read More
Gender:
ALL
Ages:
All
Trial Updated:
09/11/2020
Locations: University of Colorado Denver, Aurora, Colorado
Conditions: Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Familial Interstitial Pneumonia
The Immune System's Response to Young Women's Breast Cancer
Recruiting
This study plans to learn more about the immune system's response to breast cancer in young women.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
12/06/2024
Locations: University of Colorado Denver, Aurora, Colorado +1 locations
Conditions: Breast Cancer, Breast Cancer and Pregnancy
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Children's of Alabama, Birmingham, Alabama
Conditions: Infusion Reactions
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Recruiting
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to: 1. Compare stent and non-stent... Read More
Gender:
ALL
Ages:
All
Trial Updated:
12/05/2023
Locations: Arkansas Heart Institute, Little Rock, Arkansas
Conditions: Peripheral Arterial Disease
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
Recruiting
The purpose of this study is to compare two biologic methods for the treatment of articular cartilage defects in the knee. The first method, microfracture, is the standard of care and is routinely used to recruit cells from the subchondral bone marrow to the site of cartilage loss. The second method is the application of adipose-derived stem cells (ADSCs) to the defect site. In theory, ADSCs on a collagen scaffold should enable the delivery of more specific progenitor cells to the site of injury... Read More
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
04/24/2024
Locations: Stanford Medical Outpatient Center, Redwood City, California
Conditions: Degenerative Lesion of Articular Cartilage of Knee
Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
Recruiting
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from: * People signed up by the investigators at the University of Colorado Denver * University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Be... Read More
Gender:
ALL
Ages:
Between 1 year and 75 years
Trial Updated:
12/14/2022
Locations: University of Colorado School of Medicine, Denver, Colorado
Conditions: Peanut Allergies, Tree Nut Allergies, Other Food Allergies
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/29/2024
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +11 locations
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Recruiting
This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: GSK Investigational Site, Goodyear, Arizona +1 locations
Conditions: Neoplasms
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Recruiting
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2024
Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona
Conditions: Multiple Myeloma

Test drugs or medical treatments — get paid. With paid clinical trials, you can earn up to $600. Depending on the trial phase and potential risks or complications, you may be able to earn thousands of dollars. 

Plus, many paid trials provide complimentary medical coverage or medications. This makes it a go-to choice for those who’ve run out of options or want to save some money on medical expenses.

For example, as a healthy adult who wants to test a new cholesterol medication, you would need to stay in the research facility for a couple of nights. In cases such as these, the pay can reach a few thousand dollars. You may also get snacks and meals every day. The facility is also equipped with providing Wi-Fi and other leisure activities to pass the time.

Clinical Trials For Health Volunteers in Denver 

Without clinical trials, there can be no new drugs or medical treatments. It’s impossible to create effective preventive strategies and find cures for serious diseases.

Both sick patients and healthy volunteers can participate in clinical trials in Denver, Colorado. By taking part in a clinical trial, you help speed up the progress toward potential prevention and treatment methods. 

Data collected from a wide range of health volunteers help scientists create customized medications or therapies to accommodate the needs of different patients. This way, you are taking a more active role in your own health care.

Make your mark on healthcare history. Sign up for a clinical trial and be a part of groundbreaking research.

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
Recruiting
This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and PD study of injectable LB administered as an IM or SQ injection at 40 mg, and subsequently at 50mg SQ and then 60 mg SQ depending on the preliminary pharmacokinetic and pharmacodynamic results obtained with 40 mg dosing.
Gender:
FEMALE
Ages:
Between 18 years and 40 years
Trial Updated:
08/11/2023
Locations: University of California, Davis, Davis, California
Conditions: Healthy Women, Female Contraception

Medical Discoveries and Innovation in Denver

Denver has been booming in the last couple of years. Even the pandemic was unable to hinder the city’s growth. Colorado’s capital is expected to keep climbing, not just as a national, but international destination. 

Many Denver-based medical facilities have made notable contributions to innovation, healthcare growth, and management. 

Denver has become a thriving center for medical startups. It is quickly approaching the level of innovation seen in Silicon Valley and Cambridge. CU Anschutz is a leading academic medical campus. Their clinical studies excel in medicine, healthcare, revolutionary education, and innovation. They have more than 2 million patient visits every year, some of which sign up for clinical trials.

The largest research campus in Colorado is in Aurora, not Denver, and it lists separately:

  • Aurora — about 987 recruiting studies: the CU Anschutz Medical Campus, UCHealth University of Colorado Hospital, and Children’s Hospital Colorado

Aurora lists more recruiting studies than Denver itself, and the campus is roughly 20 minutes east of downtown, so searching both cities is essential here.

Denver Paid Clinical Trial FAQs

  • How much do paid clinical trials pay here?

    Most outpatient studies pay $50–$100 per completed visit, plus travel reimbursement. Residential Phase 1 studies pay considerably more. The exact amount appears in the consent form before you enroll.

  • Why does the University of Colorado not appear in Denver listings?

    Its medical campus, Anschutz, is located in Aurora, a separate city in the metro area. Studies list Aurora as their location, so searching Aurora alongside Denver reveals a large number of additional trials within a short drive.

  • What conditions are best represented in Denver?

    Respiratory disease is a particular strength thanks to National Jewish Health, which specializes in asthma, COPD, and other lung conditions. Blood cancers and community oncology are also well covered through the Colorado Blood Cancer Institute and Rocky Mountain Cancer Centers.

Why Denver Is A Great Place For Clinical Research 

Denver boasts a thriving medical community, with world-class hospitals and institutions, that are actively engaged in research. The city’s diverse demographic makeup provides a good pool of data capable of driving medical progress forward.

Data shows that 76.1% of the city’s residents are White, 9.2% are Black, 6.1% are Other, 3.8% are Multiracial, 3.7% Asian, 0.9% American Indian and 0.2% Native Hawaiian. Also, about 29.9% of its residents identify as Hispanic.